Table 4.
Covariate | Multivariate analysis |
|||
---|---|---|---|---|
HR | 95% CI | p value | ||
BCA parameters | ||||
AFP | Continuous | 1.0 | 1.0–1.1 | 0.347 |
Albumin | Continuous | 0.6 | 0.5–0.7 | <0.001 |
Bilirubin | Continuous | 1.2 | 1.1–1.3 | <0.001 |
AST level | Continuous | 1.1 | 1.0–1.2 | 0.003 |
INR level | Continuous | 1.0 | 0.9–1.1 | 0.524 |
Tumor number | Continuous | 1.1 | 1.0–1.2 | 0.116 |
Max. lesion size | Continuous | 1.3 | 1.1–1.5 | <0.001 |
SM normalized∗ | Continuous | 0.9 | 0.8–1.0 | 0.039 |
TAT normalized∗ | Continuous | 1.0 | 1.0–1.0 | 0.424 |
SAT normalized∗ |
Continuous |
1.0 |
1.0–1.0 |
0.349 |
BCA parameters/Bone | ||||
AFP | Continuous | 1.0 | 1.0–1.1 | 0.306 |
Albumin | Continuous | 0.6 | 0.5–0.7 | <0.001 |
Bilirubin | Continuous | 1.2 | 1.1–1.3 | <0.001 |
AST level | Continuous | 1.1 | 1.0–1.2 | 0.005 |
INR level | Continuous | 1.0 | 0.9–1.1 | 0.686 |
Tumor number | Continuous | 1.1 | 1.0–1.2 | 0.044 |
Max. lesion size | Continuous | 1.3 | 1.1–1.5 | <0.001 |
SM/Bone | Continuous | 0.9 | 0.8–1.0 | 0.036 |
TAT/Bone |
Continuous |
1.0 |
0.9–1.1 |
0.985 |
Sarcopenia marker | ||||
AFP | Continuous | 1.0 | 1.0–1.1 | 0.309 |
Albumin | Continuous | 0.6 | 0.5–0.7 | <0.001 |
Bilirubin | Continuous | 1.2 | 1.1–1.3 | <0.001 |
AST level | Continuous | 1.1 | 1.0–1.2 | 0.006 |
INR level | Continuous | 1.0 | 0.9–1.1 | 0.694 |
Tumor number | Continuous | 1.1 | 1.0–1.2 | 0.044 |
Max. lesion size | Continuous | 1.3 | 1.1–1.5 | <0.001 |
Sarcopenia marker | Continuous | 0.9 | 0.8–1.0 | 0.030 |
p values in bold show significant values.
AFP, alpha fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; IMAT, intermuscular adipose tissue; INR, international normalized ratio; SAT, subcutaneous adipose tissue; SM, skeletal muscle volume; TAT, total adipose tissue; VAT, visceral adipose tissue.
Volumes normalized to the slice number of the abdominal cavity.